Rice Hall James & Associates LLC Has $3.84 Million Stock Holdings in Iradimed Corporation (NASDAQ:IRMD)

Rice Hall James & Associates LLC lessened its holdings in shares of Iradimed Corporation (NASDAQ:IRMD) by 2.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 69,878 shares of the medical equipment provider’s stock after selling 1,721 shares during the period. Rice Hall James & Associates LLC’s holdings in Iradimed were worth $3,843,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of IRMD. SG Americas Securities LLC acquired a new stake in Iradimed during the 3rd quarter worth $147,000. Allspring Global Investments Holdings LLC increased its position in shares of Iradimed by 14.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 20,122 shares of the medical equipment provider’s stock valued at $1,012,000 after buying an additional 2,538 shares in the last quarter. Copeland Capital Management LLC increased its position in shares of Iradimed by 0.3% in the 3rd quarter. Copeland Capital Management LLC now owns 422,425 shares of the medical equipment provider’s stock valued at $21,244,000 after buying an additional 1,433 shares in the last quarter. Albert D Mason Inc. bought a new stake in shares of Iradimed in the 3rd quarter valued at $737,000. Finally, Semanteon Capital Management LP bought a new stake in shares of Iradimed in the 3rd quarter valued at $331,000. Institutional investors and hedge funds own 92.34% of the company’s stock.

Insider Transactions at Iradimed

In related news, CFO John Glenn sold 2,500 shares of the firm’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $54.18, for a total value of $135,450.00. Following the completion of the sale, the chief financial officer now directly owns 4,383 shares in the company, valued at approximately $237,470.94. This trade represents a 36.32 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Company insiders own 37.10% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently commented on IRMD. Roth Mkm restated a “buy” rating and issued a $72.00 price objective (up previously from $60.00) on shares of Iradimed in a research report on Friday, February 14th. StockNews.com cut shares of Iradimed from a “strong-buy” rating to a “buy” rating in a research report on Thursday, February 13th.

Iradimed Trading Up 3.2 %

Shares of NASDAQ IRMD opened at $56.97 on Wednesday. The company has a fifty day moving average price of $57.21 and a 200 day moving average price of $52.25. Iradimed Corporation has a 1-year low of $40.18 and a 1-year high of $63.29. The firm has a market cap of $721.81 million, a PE ratio of 39.02 and a beta of 0.82.

Iradimed (NASDAQ:IRMD) last posted its quarterly earnings data on Thursday, February 13th. The medical equipment provider reported $0.40 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.05). Iradimed had a return on equity of 23.99% and a net margin of 26.12%. The business had revenue of $19.39 million for the quarter, compared to analyst estimates of $19.09 million. Equities research analysts forecast that Iradimed Corporation will post 1.52 EPS for the current year.

Iradimed Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 5th. Stockholders of record on Monday, February 24th will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.19%. This is an increase from Iradimed’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend is Monday, February 24th. Iradimed’s dividend payout ratio is currently 41.10%.

About Iradimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.